Evidence map›Paper›PMID 41262586›Full record

ReviewACS pharmacology & translational science2025

Navigating Cancer Treatment: A Journey from 2D to 3D Cancer Models and Nanoscale Therapies.

Navneet Kaur, Mary Jean Savitsky, Annie Scutte, Roshani Mehta, Narjes Dridi, Taiwo Sogbesan, Alexyss Savannah, Damian Lopez, Dazhi Yang, Jamel Ali

Abstract readReview
In one paragraph

Review in ACS pharmacology & translational science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Navneet KaurDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Tallahassee, Florida 32310, United States.ORCID https://orcid.org/0000-0003-4543-370X
Mary Jean SavitskyDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Tallahassee, Florida 32310, United States.
Annie ScutteDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Tallahassee, Florida 32310, United States.
Roshani MehtaDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Tallahassee, Florida 32310, United States.
Narjes DridiDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Tallahassee, Florida 32310, United States.ORCID https://orcid.org/0000-0001-9267-5475
Taiwo SogbesanDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Tallahassee, Florida 32310, United States.
Alexyss SavannahDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Tallahassee, Florida 32310, United States.
Damian LopezDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Tallahassee, Florida 32310, United States.
Dazhi YangAcrogenic Technologies Inc., Rockville, Maryland 20850, United States.
Jamel AliDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Tallahassee, Florida 32310, United States.ORCID https://orcid.org/0000-0002-2997-1981

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer remains one of the most significant global health challenges, characterized by an increasing incidence and mortality rate worldwide.

Indexed as

3D bioprinting3D cell culturemicroparticlesnanoparticles uptakenanotechnologyorganoids

Identifiers

PMID41262586
PMCPMC12624436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.